Breast cancer and hormone-replacement therapy: the Million Women Study
about
Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtypeDifferences in menopausal hormone therapy use among women in Germany between 1998 and 2003Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neuronsShort and long term effects of tibolone in postmenopausal womenTibolone for menopausal symptomsBias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast CancerRed-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]The changing global patterns of female breast cancer incidence and mortalityTowards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cellsThe effect of Fucus vesiculosus, an edible brown seaweed, upon menstrual cycle length and hormonal status in three pre-menopausal women: a case reportMenopausal hormone therapy after breast cancerVariation in the psychosocial determinants of the intention to prescribe hormone therapy prior to the release of the Women's Health Initiative trial: a survey of general practitioners and gynaecologists in France and Quebec.The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells.Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice.Molecular determinants of context-dependent progesterone receptor action in breast cancerA prospective study of postmenopausal hormone use and ovarian cancer riskAddressing the soy and breast cancer relationship: review, commentary, and workshop proceedingsRaloxifene and desmethylarzoxifene block estrogen-induced malignant transformation of human breast epithelial cellsInferring gene dependency network specific to phenotypic alteration based on gene expression data and clinical information of breast cancerLong-term hormone therapy for perimenopausal and postmenopausal women.Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis.Deciphering the divergent roles of progestogens in breast cancer.Cardiac glycosides and breast cancer risk: A systematic review and meta-analysis of observational studies.Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological stuTransdermal natural progesterone cream for postmenopausal women: inconsistent data and complex pharmacokinetics.Breast cancer tumor growth estimated through mammography screening dataRemarkable change in age-specific breast cancer incidence in the Swiss canton of Geneva and its possible relation with the use of hormone replacement therapyHormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study.Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial CohortMenopausal hormone therapy: a systematic review of cost-effectiveness evaluations.An investigation of breast cancer risk factors in Cyprus: a case control studyIcariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.Role of endogenous and exogenous female sex hormones in arthritis and osteoporosis development in B10.Q-ncf1*/* mice with collagen-induced chronic arthritis.NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyRecent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohortProgesterone receptor action: defining a role in breast cancer
P2860
Q21195226-ED52C4CB-4099-4897-919A-BDFEB130BF33Q21254698-A234CE72-C842-4E19-B76B-B63E947134A9Q21562188-B7CF47AA-3645-4D61-AE9D-0F938FB0C72BQ24203695-07F4DC43-C141-4379-8EF5-B909AFAEBFE7Q24235220-81D2368D-93F5-4BDA-AA93-44069685BABBQ24288665-C6A2456E-B510-4EAA-B065-A1B2FFA1E04DQ24794752-62D68C33-F859-450F-84FC-04858175B410Q24795947-F72BC58B-D0AA-427B-BCB7-754C041BADECQ24796913-890CE0EA-6AC0-44F5-BA96-13A2ADD35DE0Q24801958-8F8ACE15-F18F-4DC1-B54B-6D404D5AA8E4Q24810837-93F478A4-95BB-4DFE-A166-1CC1D74806ACQ24816999-33D4F7BB-27DB-4AFB-9F39-B69C7D183DC6Q25257485-D8E49BF5-ABAE-4FF0-96F7-431E46C48B2EQ25257729-6CAD5047-F667-4A79-8E34-C073F3F421BFQ26997928-48656BAB-8FB9-4616-BF70-3D0C7C7EEDE1Q28213056-DAD1759A-60D4-49C9-8A54-ED75480B704EQ28264426-362197A9-87B4-43A1-A2A2-F4E262BB6557Q28478183-2CF10043-2ADF-4F1F-9232-784A3F2A669FQ30000682-143CA7A4-B7E7-4C84-A44A-C45327EFD4E3Q30238978-FC795A21-4536-4B6E-AE18-813C72D8F342Q30239742-5314EF0D-2856-4012-B143-002189EEE6EEQ30240711-D0DD7F9C-0AAB-4934-912D-7A638EF95702Q30241045-5261244E-87D1-4192-87E6-42EE01136652Q30479247-12764059-DB57-48DC-BEB2-E90419F4EA30Q31009526-0DF66532-B4D5-4BDB-88AA-050BCCFB3DA8Q31036814-EA4238D1-D530-493A-ADD7-4D3562ED7DC5Q31080770-AFCB6DD6-A24B-408F-8A46-B5EAEF4B19C8Q31136140-B6ED4FC7-A6D2-45BE-A649-BB1FCA70440DQ31154970-7BA13ED3-C924-473A-A3B4-699D153DB3B4Q33237199-6D8E5F8A-0C79-4774-AD7B-632A064E75B0Q33248484-B1A52D83-88AD-45B8-A50D-669C2C0C85F1Q33418922-AD1D925D-8FF8-4A7F-8D55-145112B9D925Q33644735-39B3B1E3-7956-4F90-90FE-04FEFB49DAD4Q33667724-6E6C305E-BE4F-43F3-90DD-DADB8A1A1494Q33690781-294C2D44-0655-4871-A136-5336AFF9E213Q33772317-1ADA4389-DBED-4595-B54D-618A57C62AC2Q33844463-7FB73BC4-C6B8-4541-977C-40EF0A22B1D0Q33889458-5E48091D-16C7-45BA-82BE-C2CB190365EBQ33892873-322C2995-38B0-4062-A2D3-19E207ED4423Q33998721-0457352B-D0DA-4F66-B878-3A8677F0D0FD
P2860
Breast cancer and hormone-replacement therapy: the Million Women Study
description
article publié dans la revue scientifique The Lancet
@fr
im Oktober 2003 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
наукова стаття, опублікована в жовтні 2003
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Breast cancer and hormone-replacement therapy: the Million Women Study
@en
type
label
Breast cancer and hormone-replacement therapy: the Million Women Study
@en
prefLabel
Breast cancer and hormone-replacement therapy: the Million Women Study
@en
P50
P1433
P1476
Breast cancer and hormone-replacement therapy: the Million Women Study
@en
P2093
Diana Bull
P304
P356
10.1016/S0140-6736(03)14596-5
P407
P577
2003-10-01T00:00:00Z